title: FDG PET/CT findings in recurrent malignant schwannoma.
abstract: Malignant schwannoma is an uncommon but aggressive sarcoma that most commonly arises in young and middle-aged adults. We present a 28-year-old male patient with a recurrent chest wall malignant schwannoma. An FDG PET/CT was performed to evaluate the management of the patient. The PET/CT images showed hypermetabolic mass lesions in the left upper chest wall and increased FDG uptake in the left axillary region. The pathologic results confirmed the PET findings. We conclude that FDG PET/CT could play an important role in the staging, restaging, and post-therapy follow-up of malignant schwannomas.
authors.affiliation: Department of Nuclear Medicine, Cerrahpaçsa Medical Faculty, University of Istanbul, Istanbul, Turkey. metinhallac@yahoo.com
authors.forename: Metin
authors.initials: M
authors.lastname: Halac
authors.forename: Ferahnaz
authors.initials: F
authors.lastname: Cnaral
authors.forename: Sager
authors.initials: S
authors.lastname: Sait
authors.forename: Selda
authors.initials: S
authors.lastname: Ylmaz
authors.forename: Sönmezoglu
authors.initials: S
authors.lastname: Kerim
authors.forename: Dervisoglu
authors.initials: D
authors.lastname: Sergülen
authors.forename: Ilhami
authors.initials: I
authors.lastname: Uslu
mesh_terms: D000328:Adult; D001365:Axilla / Q000000981:diagnostic imaging; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D019042:Muscle Neoplasms / Q000000981:diagnostic imaging*; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009442:Neurilemmoma / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D011859:Radiography; D019275:Radiopharmaceuticals; D035441:Thoracic Wall / Q000000981:diagnostic imaging*; D014055:Tomography, Emission-Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18